REPLIGEN CORP Restricted Cash and Cash Equivalents, Noncurrent
REPLIGEN CORP (RGEN) had Restricted Cash and Cash Equivalents, Noncurrent of $9.00 million as of 2020-06-30, per its 10-K filed 2022-02-17.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:RestrictedCashAndCashEquivalentsNoncurrent · last filed 2022-02-17
- 2020-06-30: Restricted Cash and Cash Equivalents, Noncurrent $9.00M.
- 2019-12-31: Restricted Cash and Cash Equivalents, Noncurrent $9.00M.
- 2017-09-30: Restricted Cash and Cash Equivalents, Noncurrent $450.00K.
- 2017-06-30: Restricted Cash and Cash Equivalents, Noncurrent $450.00K.
| Period end | Restricted Cash and Cash Equivalents, Noncurrent |
|---|---|
| 2020-06-30 | $9.00M 10-K · filed 2022-02-17 |
| 2019-12-31 | $9.00M 10-K · filed 2022-02-17 |
| 2017-09-30 | $450.00K 10-Q · filed 2017-11-09 |
| 2017-06-30 | $450.00K 10-Q · filed 2017-08-03 |
| 2017-03-31 | $450.00K 10-Q · filed 2017-05-04 |
| 2016-12-31 | $450.00K 10-K · filed 2018-02-22 |
| 2016-09-30 | $450.00K 10-Q · filed 2016-11-03 |
| 2016-06-30 | $450.00K 10-Q · filed 2016-08-04 |
| 2016-03-31 | $450.00K 10-Q · filed 2016-05-05 |
| 2015-12-31 | $450.00K 10-K · filed 2017-02-23 |
| 2015-09-30 | $450.00K 10-Q · filed 2015-11-05 |
| 2015-06-30 | $450.00K 10-Q · filed 2015-08-06 |
| 2015-03-31 | $450.27K 10-Q · filed 2015-05-08 |
| 2014-12-31 | $450.00K 10-K · filed 2016-02-25 |
| 2014-09-30 | $450.00K 10-Q · filed 2014-11-07 |
| 2014-06-30 | $450.00K 10-Q · filed 2014-08-11 |
| 2014-03-31 | $200.00K 10-Q · filed 2014-05-09 |
| 2013-12-31 | $200.00K 10-K · filed 2015-03-17 |
| 2013-09-30 | $200.00K 10-Q · filed 2013-11-08 |
| 2013-06-30 | $200.00K 10-Q · filed 2013-08-07 |
| 2013-03-31 | $200.00K 10-Q · filed 2013-05-07 |
| 2012-12-31 | $200.00K 10-K · filed 2014-03-14 |
| 2012-09-30 | $200.00K 10-Q · filed 2012-11-08 |
| 2012-06-30 | $200.00K 10-Q · filed 2012-08-09 |
| 2012-03-31 | $200.00K 10-Q · filed 2012-05-10 |
| 2011-12-31 | $200.00K 10-K · filed 2013-03-15 |
| 2011-09-30 | $200.00K 10-Q · filed 2011-11-09 |
| 2011-06-30 | $200.00K 10-Q · filed 2011-08-05 |
| 2011-03-31 | $200.00K 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |